gastric%20cancer
GASTRIC CANCER
Gastric cancer is the cancer originating in the esophagus, esophagogastric junction and stomach.
Most of gastric cancers are adenocarcinomas, subdivided according to histological appearances into diffuse (undifferentiated) and intestinal (well differentiated) types.
It is the 4th most common cancer and the 2nd most common cause of cancer-related deaths worldwide.
Most common sites of gastric cancer are the proximal lesser curvature, cardia and esophagogastric junction.

Introduction

  • Fourth most common cancer & second most common cause of cancer-related deaths worldwide
    • In Japan, this is the most common type of cancer in men
  • Most common sites of gastric cancer are the proximal lesser curvature, cardia & esophagogastric junction

Definition

  • Cancers originating in the esophagus, esophagogastric junction & stomach
  • Most of gastric cancers (90%) are adenocarcinomas, subdivided according to histological appearances into diffuse (undifferentiated) & intestinal (well-differentiated) types (Lauren classification)

Signs and Symptoms

  • Early stage gastric cancer rarely causes symptoms
    • Most commonly diagnosed at an advanced stage
  • Dyspepsia is the early stage symptom
  • Advanced stage signs & symptoms include:
    • Poor appetite
    • Weight loss
    • Dysphagia
    • Abdominal pain
    • Vague abdominal discomfort, usually above the navel
    • A sense of fullness in the upper abdomen after eating a small meal (early satiety)
    • Heartburn or indigestion
    • Nausea & vomiting
    • Swelling or fluid build-up in the abdomen
    • Iron-deficiency anemia

Risk Factors

  • Male
  • Old age (>50 years old)
  • Helicobacter pylori infection
    • Usually the major cause
  • Cigarette/tobacco use
  • Previous gastric surgery eg partial gastrectomy
  • Menetrier’s disease or hypertrophic gastropathy
  • Atrophic gastritis
  • Diet that has large amounts of smoked foods, salted fish & meat & pickled vegetables
    • Nitrates & nitrites on these foods have shown to produce bacteria that causes cancer
  • Stomach lymphoma
  • Pernicious anemia
  • Type A blood
  • Overweight or obesity
  • Inherited cancer syndromes (3-5%) eg hereditary diffuse gastric cancer, hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, breast cancer, Li-Fraumeni syndrome, Peutz-Jeghers syndrome
  • Family history of stomach cancer (5-10%)
  • Epstein-Barr virus
  • Certain occupations eg coal, metal & rubber industry workers
  • Common variable immune deficiency
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Natalia Reoutova, 21 Nov 2019

Final analysis of the POEMS (Prevention of Early Menopause) study finds that breast cancer (BC) patients treated with the gonadotrophin-releasing hormone agonist (GnRHa) goserelin, in addition to chemotherapy, are more likely to avoid premature menopause and to become pregnant without negatively impacting disease-related outcomes.

Jairia Dela Cruz, 04 Dec 2019
In breast cancer, especially hormone-negative tumours, an ultrasound-guided core biopsy (CNB) is useful for predicting pathologic complete response (pCR) to chemotherapy and may thus help to avoid surgery for some patients, a study has found.
Stephen Padilla, 05 Dec 2019
Circulating miR-155 may be potentially used as a diagnostic and therapeutic monitoring marker in breast cancer, suggests an Indonesian study presented at the 2019 Asia Congress of the European Society for Medical Oncology (ESMO Asia 2019).
Christina Lau, 14 Feb 2019
Progress in the treatment of rare cancers has been named Advance of the Year by the American Society of Clinical Oncology (ASCO).